
Bio-Rad Laboratories, Inc.
BIONYSEHealthcareMedical - Devices
Previous close
$380.03
+$3.57 · +0.95%
BIO company overview
Historical prices · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
64
Undervalued
Momentum
42
Neutral
Sentiment
66
Bullish
Risk resilience
64
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteBio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Norman D. Schwartz
- Listed since
- Feb 27, 1980
- Employees
- 7,450
Market position
Day range
Current $380.03
52-week range
Current $380.03
- Open
- $385.8
- Previous close
- $376.46
- Volume
- 302.71K
- 0.85× average
- Average volume
- 354.9K
- Average daily volume
- Market cap
- 10.23B USD
- Beta
- 1.05
- Market reference 1
- 50-day average
- $315.93
- +20.29% above average
- 200-day average
- $298.24
- +27.43% above average
Earnings
- Latest fiscal-year EPS
- 27.87
- FY2025
- Latest fiscal-year revenue
- 2.58B USD
- FY2025 · +0.65% year over year
- Next fiscal-year EPS consensus
- 9.64
- FY2026 · 2 analysts
- Next fiscal-year revenue consensus
- 2.58B USD
- FY2026 · 3 analysts
Annual EPS trend
Reported history and fiscal-year consensus
Annual revenue trend
Reported history and fiscal-year consensus
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$350
7.90% downsideRating distribution
14 ratingsBIO peers
ETFs holding BIO
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Mid-Cap ETFIJH221.32M0.17%125.92B USD0.05%$76.77+0.52%
Vanguard Morningstar Total Stock Market ETFVTI190.95M0.01%2.3T USD0.03%$378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB138.06M0.07%183.4B USD0.03%$304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR87.66M0.13%68.3B USD0.05%$249.18+0.68%
Vanguard Extended Market ETFVXF67.51M0.07%93.7B USD0.05%$245.53+0.82%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY49.66M0.19%26.72B USD0.23%$699.6+0.48%
Dimensional - US Small Cap Value ETFDFSV45.36M0.54%8.42B USD0.30%$40.29+0.72%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD35.23M0.19%18.77B USD0.03%$67.27+0.52%
iShares Core S&P Mid-Cap ETFIJH- Market value
- 221.32M
- Weight
- 0.17%
- AUM
- 125.92B USD
- Expense ratio
- 0.05%
- Price / 1D
- $76.77+0.52%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 190.95M
- Weight
- 0.01%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 138.06M
- Weight
- 0.07%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR- Market value
- 87.66M
- Weight
- 0.13%
- AUM
- 68.3B USD
- Expense ratio
- 0.05%
- Price / 1D
- $249.18+0.68%
Vanguard Extended Market ETFVXF- Market value
- 67.51M
- Weight
- 0.07%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY- Market value
- 49.66M
- Weight
- 0.19%
- AUM
- 26.72B USD
- Expense ratio
- 0.23%
- Price / 1D
- $699.6+0.48%
Dimensional - US Small Cap Value ETFDFSV- Market value
- 45.36M
- Weight
- 0.54%
- AUM
- 8.42B USD
- Expense ratio
- 0.30%
- Price / 1D
- $40.29+0.72%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD- Market value
- 35.23M
- Weight
- 0.19%
- AUM
- 18.77B USD
- Expense ratio
- 0.03%
- Price / 1D
- $67.27+0.52%
Continue in GoAI
Research BIOresearch.disclaimer





